The trade-off between costs and quality of care in the treatment of psychosomatic patients with somatoform pain disorder

Applied Health Economics and Health Policy

Volumn 11, Issue 4, 2013, Pages 359-368

  Haas, Laura ^a   Stargardt, Tom ^b   Schreyoegg, Jonas ^b,c   Schlösser, Rico ^d   Klapp, Burghard F ^a   Danzer, Gerhard ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF HAMBURG   (Germany)

^c STANFORD UNIVERSITY   (United States)

^d BERLIN SCHOOL OF ECONOMICS AND LAW   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CALCULATION; FEMALE; HEALTH CARE COST; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; HUMAN; ICD-10; MAJOR CLINICAL STUDY; MALE; MORBIDITY; OUTCOME VARIABLE; PSYCHOGENIC PAIN; SHORT FORM 8;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; GERMANY; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PAIN; PSYCHOPHYSIOLOGIC DISORDERS; QUALITY OF HEALTH CARE; QUESTIONNAIRES; SOMATOFORM DISORDERS; YOUNG ADULT;

EID: 84880880048     PISSN: 11755652     EISSN: 11791896     Source Type: Journal    
DOI: 10.1007/s40258-013-0042-0     Document Type: Article

References (52)

1. Drozd EM, Cromwell J, Gage B, et al. Patient casemix classification for medicare psychiatric prospective payment. Am J Psychiatry. 2006;163:724-32. (Pubitemid 44464585)
2. Geissler A, Quentin W. Prospective payment for inpatient psychiatric care. Health Policy Monitor, 2010. http://www.hpm.org/en/Surveys/TU-Berlin-D/15/ Prospective-payment-for-inpatient-psychiatric-care.html. Accessed 2012 Oct 15.
3. Mason A, Goddard M. Payment by results in mental health: a review of the international literature and an economic assessment of the approach in the English NHS. University of York, 2009. http://www.york.ac.uk/che/pdf/rp50.pdf. Accessed 2012 Oct 15.
4. Schreyoegg J, Stargardt T. The trade-off between costs and outcomes: the case of acute myocardial infarction. Health Serv Res. 2010;45:1585-601.
5. Cots F, Chiarello P, Salvador X, et al. DRG-based hospital payment: intended and unintended consequences. In: Busse R, Geissler A, Quentin W, et al., editors. Diagnosis-related groups in Europe. Berkshire: McGraw-Hill Open University Press; 2011. p. 75-92.
6. Fleming ST. The relationship between quality and cost: pure and simple? Inquiry. 1991;28:29-387.
7. Carey K, Burgess JF Jr. On measuring the hospital cost/quality trade-off. Health Econ. 1999;8:509-20. (Pubitemid 29462242)
8. Mukamel DB, Spector WD. Nursing home costs and risk-adjusted outcome measures of quality. Med Care. 2000;38:78-89.
9. Stargardt T, Schreyoegg J, Kondofersky I. Measuring the relationship between costs and outcomes: the example of acute myocardial infarction in German hospitals. Health Econ. 2013. doi: 10.1002/hec.2941
10. Romley JA, Jena AB, Goldman DP. Hospital spending and inpatient mortality: evidence from California: an observational study. Ann Intern Med. 2011;154:160-7.
11. Stukel TA, Fisher ES, Alter DA, et al. Association of hospital spending intensity with mortality and readmission rates in Ontario hospitals. J Am Med Assoc. 2012;307:1037-45.
12. Jha AK, Orav EJ, Dobson A, et al. Measuring efficiency: the association of hospital costs and quality of care. Health Aff. 2009;28:897-906.
13. Lagu T, Rothberg MB, Nathanson BH, et al. The relationship between hospital spending and mortality in patients with sepsis. Arch Intern Med. 2011;171:292-9.
14. Chen LM, Jha AK, Guterman S, et al. Hospital cost of care, quality of care, and readmission rates: penny wise and pound foolish? Arch Intern Med. 2010;170:340-6.
15. World Health Organization. The ICD-10 classification of mental and behavioural disorders: diagnostic criteria for research. World Health Organization, 1993. http://www.who.int/classifications/icd/en/GRNBOOK.pdf. Accessed 2013 Jun 25.
16. Froehlich C, Jacobi F, Wittchen HU. DSM-IV pain disorder in the general population. Eur Arch Psychiatry Clin Neurosci. 2006;256:187-96.
17. Grabe HJ, Meyer C, Hapke U, et al. Somatoform pain disorder in the general population. Psychother Psychosom. 2003;72:88-94. (Pubitemid 36302477)
18. Hiller W, Fichter MM, Rief W. A controlled treatment study of somatoform disorders including analysis of healthcare utilization and cost-effectiveness. J Psychosom Res. 2003;54:369-80. (Pubitemid 38366002)
19. Rost K, Kashner TM, Smith GR. Effectiveness of psychiatric intervention with somatization disorder patients: improved outcomes at reduced costs. Gen Hosp Psychiatry. 1994;16:381-7. (Pubitemid 24355863)
20. Escobar JI, Golding JM, Hough RL, et al. Somatization in the community: relationship to disability and use of services. Am J Pub Health. 1987;77:837-40. (Pubitemid 17090349)
21. Shaw J, Creed F. The cost of somatization. J Psychosom Res. 1991;35:307-12.
22. Treurniet HF, Essink-Bot ML, Mackenbach JP, et al. Health-related quality of life: an indicator of quality of care? Qual Life Res. 1997;6:363-9. (Pubitemid 27294730)
23. Wilson IB, Cleary PD. Linking clinical variables with health-related quality of life. J Am Med Assoc. 1995;273:59-65.
24. Tan SS, Rutten FF, van Ineveld BM, et al. Comparing methodologies for the cost estimation of hospital services. Eur J Health Econ. 2009;10:39-45.
25. Donabedian A. Basic approaches to assessment: structure, process and outcome. Explorations in Quality Assessment and Monitoring. 1980;1:75-125.
26. Donabedian A. Evaluating the quality of medical care. Milbank Quart. 2005;83:691-729. (Pubitemid 43127783)
27. Patrick DL, Bergner M. Measurement of health status in the 1990s. Annu Rev Public Health. 1990;11:165-83. (Pubitemid 20157389)
28. Ebrahim S. Clinical and public health perspectives and applications of health-related quality of life measurement. Soc Sci Med. 1995;41:1383-94.
29. Ware JE Jr. The status of health assessment 1994. Annu Rev Public Health. 1995;16:327-54.
30. Kilbourne AM, Keyser D, Pincus HA. Challenges and opportunities in measuring the quality of mental health care. Can J Psychiatry. 2010;55:549-57.
31. Martin M, Blaisdell-Gross B, Fortin EW, et al. Health-related quality of life of heart failure and congestive artery disease patients improved during participation in disease management programs: a longitudinal observational study. Dis Manag. 2007;10:164-78. (Pubitemid 47400547)
32. Mainz J. Defining and classifying clinical indicators for quality improvement. Int J Qual Health Care. 2003;15:523-30. (Pubitemid 37540789)
33. Ware JE, Kosinski M, Dewey JE, et al. How to score and interpret single-item health status measures: a manual for users of the of the SF-8 Health Survey. Lincoln: Qual Metr; 2001.
34. Turner-Bowker DM, Bayliss MS, Ware JE, et al. Usefulness of the SF-8 Health Survey for comparing the impact of migraine and other conditions. Qual Life Res. 2003;12:1003-12. (Pubitemid 37386628)
35. Walker DR, Landis DL, Stern PM, et al. Disease management positively affects patient quality of life. Manag Care Interface. 2003;16:56-60. (Pubitemid 36523496)
36. Lefante JJ, Harmon GN, Ashby KM, et al. Use of the SF-8 to assess health-related quality of life for a chronically ill, low-income population participating in the Central Louisiana Medication Access Program (CMAP). Qual Life Res. 2005;14:665-73. (Pubitemid 40576853)
37. Wooldridge JM. Econometric analysis of cross section and panel data. Cambridge: MIT Press; 2002.
38. Hausman JA. Specification tests in econometrics. Econometrica. 1978;46:1251-71.
39. Cohen J. Statistical power analysis for the behavioral sciences. Hillsdale: Lawrence Erlbaum; 1988.
40. Samsa G, Edelman D, Rothman ML, et al. Determining clinically important differences in health status measures: a general approach with illustration to the Health Utilities Index Mark II. Pharmacoeconomics. 1999;15:141-55. (Pubitemid 29093257)
41. Ware JE. User's manual for the SF-36v2 Health Survey. Lincoln: Qual Metr; 2007.
42. Huber D, Albrecht C, Hautum A, et al. Effectiveness of inpatient psychodynamic psychotherapy: a follow-up study. Z Psychosom Med Psyc. 2009;55:189.
43. Haase M, Frommer J, Franke GH, et al. From symptom relief to interpersonal change: treatment outcome and effectiveness in inpatient psychotherapy. Psychother Res. 2008;18:615-24.
44. Kroenke K. Efficacy of treatment for somatoform disorders: a review of randomized controlled trials. Psychosom Med. 2007;69:881-8. (Pubitemid 350158831)
45. Sattel H, Lahmann C, Guendel H, et al. Brief psychodynamic interpersonal psychotherapy for patients with multisomatoform disorder: randomised controlled trial. Br J Psychiatry. 2012;200:60-7.
46. Duddu V, Isaac MK, Chaturvedi SK. Somatization, somatosensory amplification, attribution styles and illness behaviour: a review. Int Rev Psychiatry. 2006;18:25-33. (Pubitemid 43201018)
47. Rief W, Nanke A, Emmerich J, et al. Causal illness attributions in somatoform disorders: associations with comorbidity and illness behavior. J Psychosom Res. 2004;57:367-71. (Pubitemid 39424250)
48. Groben S, Hausteiner C. Somatoform disorders and causal attributions in patients with suspected allergies: do somatic causal attributions matter? J Psychosom Res. 2011;70:229-38.
49. Wise TN, Mann LS. The attribution of somatic symptoms in psychiatric outpatients. Compr Psychiatry. 1995;36:407-10.
50. Kirmayer LJ, Robbins JM. Patients who somatize in primary care: a longitudinal study of cognitive and social characteristics. Psychol Med. 1996;26:937-51. (Pubitemid 26305995)
51. Mant J. Process versus outcome indicators in the assessment of quality of health care. Int J Qual Health Care. 2001;13(6):475-80. (Pubitemid 33133922)
52. Zeeck A, Wietersheim J, Hartmann, et al. Inpatient or day clinic treatment? Results of a multi-site-study. GMS Psycho Soc Med. 2009. doi: 10.3205/psm000059.